Showing results (31-40 of 39) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Cancers|March 7, 2019
Rapid Induction of Liver Regeneration for Major Hepatectomy (REBIRTH): A Randomized Controlled Trial of Portal Vein Embolisation versus ALPPS Assisted with RadiofrequencyLong R Jiao, Ana B Fajardo Puerta, Tamara M H Gall, et al.Annals of Surgical Oncology|February 8, 2011
Two-stage resection for bilobar colorectal liver metastases: R0 resection is the keyNicole Tsim, Andrew J Healey, Adam E Frampton, et al.Gut|August 17, 2012
Guidelines for the diagnosis and treatment of cholangiocarcinoma: an updateShahid A Khan, Brian R Davidson, Robert D Goldin, et al.Cancers|August 10, 2024
Prospective Study of Non-Contrast, Abbreviated MRI for Hepatocellular Carcinoma Surveillance in Patients with Suboptimal Hepatic Visualisation on UltrasoundMathew Vithayathil, Maria Qurashi, Pedro Rente Vicente, et al.BMC Cancer|March 24, 2021
PRIME-HCC: phase Ib study of neoadjuvant ipilimumab and nivolumab prior to liver resection for hepatocellular carcinomaDavid J Pinato, Alessio Cortellini, Ajithkumar Sukumaran, et al.European Journal of Nuclear Medicine and Molecular Imaging|February 16, 2026
Efficacy and evaluation of dose-response relationship of selective internal radiation therapy for the management of liver metastases in neuroendocrine neoplasiaQasim Ahmed, Nikolaos Doumanoglou, Joanne Evans, et al.The American Journal of Gastroenterology|July 19, 2008
Autologous infusion of expanded mobilized adult bone marrow-derived CD34+ cells into patients with alcoholic liver cirrhosisMadhava Pai, Dimitris Zacharoulis, Miroslav N Milicevic, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2024
Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib StudyDavid J Pinato, Antonio D'Alessio, Claudia Angela Maria Fulgenzi, et al.Stem Cells (Dayton, Ohio)|March 25, 2006
Characterization and clinical application of human CD34+ stem/progenitor cell populations mobilized into the blood by granulocyte colony-stimulating factorMyrtle Y Gordon, Natasa Levicar, Madhava Pai, et al.Pageof 4